Codex Committee on Nutrition and Foods for Special Dietary Uses (CCNFSDU)

Codex Committee on Nutrition and Foods for Special Dietary Uses (CCNFSDU)

41st Session - Düsseldorf, Germany, 24 – 29 November 2019

European Union comments on:

  • Agenda Item 4a: Review of the standard for follow-up formula (CXS 156-1987): draft scope, description and labelling for follow-up formula for older infants (codex circular letter CL 2019/77-NFSDU)
  • Agenda Item 4d: Review of the Standard for Follow-Up Formula (CODEX STAN 156-1987)
  • Agenda Item 5a: Proposed Draft Guidelines for Ready-to-use Therapeutic Foods at Step 4 (CX/NFSDU 19/41/6)
  • Agenda Item 5b: Proposed Draft Guidelines for Ready-to-use Therapeutic Foods (at Step 3)
  • Agenda Item 6: Proposed Draft Claim for “free” of Trans Fatty Acids (at step 4) and Discussion Paper on Risk management possibilities for the reduction of TFAs
  • Agenda Item 7: Proposed Draft Definition for Biofortification (at step 4)
  • Agenda Item 8: NRVs-R for Older Infants and Young Children (CX/NFSDU 19/41/8)
  • Agenda Item 12: Discussion Paper on General Guidelines to establish nutrient profiles for food labelling (CX/NFSDU 19/41/12)

European Union comments on

  • CL 2018/94-NFSDU: Request for comments at Step 5 on the Review of the Standard for Follow-up Formula: Proposed draft scope, description and labelling for follow-up formula for older infants.

40th Session - Berlin, Germany, 26 – 30 November 2018

European Union comments on:

  • Agenda Item 4b: Review of the Standard for Follow-Up Formula (CODEX STAN 156-1987) at Step 3
  • Agenda Item 5: Proposed Draft Guidelines for Ready-to-use Therapeutic Foods at Step 3
  • Agenda Item 6: Proposed Draft Definition for Biofortification

European Union comments on:

  • CL 2018/62-NFSDU: Draft Review of the Standard for Follow-up Formula: Essential composition requirements

39th Session - Berlin, Germany, 4-8 December 2017

European Union comments on:

  • Agenda Item 4 b): Review of the Standard for Follow-Up Formula (CODEX STAN 156-1987)
  • Agenda Item 4: Review of the Standard for Follow-Up Formula (CODEX STAN 156-1987)
  • Agenda Item 5: Proposed Draft Definition for Biofortification
  • Agenda Item 6: Proposed Draft NRV-NCD for EPA and DHA long chain omega-3 fatty acids (CX/NFSDU 17/39/6)
  • Agenda Item 7: Proposed Draft Guideline for Ready-to-use Therapeutic Foods
  • Agenda Item 9: Food Additives – Mechanism / Framework For Considering Technological Justification And Other Matters

38th Session - Hamburg, Germany, 5-9 December 2016

European Union comments on:

  • Agenda Item 2: Matters Referred by the Codex Alimentarius Commission and/or Other Subsidiary Bodies
  • Agenda Item 5: Review of the Standard for Follow-Up Formula (CODEX STAN 156-1987)
  • Agenda Item 6: Proposed Draft Definition for Biofortification
  • Agenda Item 7: Proposed Draft NRV-NCD for EPA and DHA long chain omega-3 fatty acids at Step 4
  • Agenda Item 8: Proposed Draft Guideline for Ready-to-use Therapeutic Foods at Step 4

European Union comments on:

  • CL 2016/19-NFSDU: Request for Comments at Step 6 on the Draft NRV-R for Vitamin E

37th Session - Bad Soden am Taunus, Germany, 23 – 27 November 2015

European Union comments on:

  • Agenda Item 2: Matters Referred by the CAC and other Committees: Part B. Matters arising from other codex subsidiary bodies
  • Agenda Item 4: Proposed Draft Additional or Revised Nutrient Reference Values for Labelling Purposes in the Guidelines on Nutrition Labelling (CX/NFSDU 15/37/4)
  • Agenda Item 5: Review of the Standard for Follow-Up Formula (CODEX STAN 156-1987) at Step 4
  • Agenda Item 7: Proposed draft NRV-NCD for EPA and DHA long chain Omega-3 fatty acids
  • Agenda Item 11a: Methods of analysis in the Standard for Infant Formulas for Special Medical Purposes Intended for Infants (CODEX STAN 72-1981)
  • Codex Circular Letter CL 2014/33-NFSDU: Matters For Adoption By The 38th Session Of The Codex Alimentarius Commission - Point 7: Proposed Draft Revision of the list of food additives in the Standard for Infant Formula and Formulas for Special Medical Purposes Intended for Infants.